The short C–H⋯S contacts found in available structural data for both small molecules and larger biomolecular systems suggest that such contacts are an often overlooked yet important stabilizing interaction.
Supramolecular
anion receptors can be used to study the molecular
recognition properties of the reactive yet biologically critical hydrochalcogenide
anions (HCh–). Achieving selectivity for HCh– over the halides is challenging but necessary for
not only developing future supramolecular probes for HCh– binding and detection, but also for understanding the fundamental
properties that govern these binding and recognition events. Here
we demonstrate that linear free energy relationships (LFERs)including
Hammett and Swain–Lupton plotsreveal a clear difference
in sensitivity to the polarity of an aryl C–H hydrogen bond
(HB) donor for HS– over other HCh– and halides. Analysis using electrostatic potential maps highlights
that this difference in sensitivity results from a preference of the
aryl C–H HB donor for HS– in this host scaffold.
From this study, we demonstrate that LFERs are a powerful tool to
gain interpretative insight into motif design for future anion-selective
supramolecular receptors and highlight the importance of C–H
HB donors for HS– recognition. From our results,
we suggest that aryl C–H HB donors should be investigated in
the next generation of HS– selective receptors based
on the enhanced HS– selectivity over other competing
anions in this system.
Synthetic supramolecular receptors have been widely used to study reversible solution binding of anions; however, few systems target highly-reactive species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.